Action of dopamine and noradrenaline on synaptic transmission in sympathetic ganglia of brown fat.
D002001:Adipose Tissue, Brown / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004336:Drug Antagonism; D005724:Ganglia / Q000187:drug effects* / Q000378:metabolism; D006426:Hemicholinium 3 / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D007531:Isoflurophate / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis / Q000494:pharmacology; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects*; D013859:Thiocarbamates / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D002614:Chelating Agents; D018492:Dopamine Antagonists; D011453:Prostaglandins; D013859:Thiocarbamates; D007531:Isoflurophate; D006426:Hemicholinium 3; D011433:Propranolol; D007490:Iproniazid; D004298:Dopamine; D014403:Tubocurarine; D009638:Norepinephrine; D010646:Phentolamine